pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

White House plan to tighten control over NIH grants stalls after bipartisan opposition

Sep 23, 2026·read at STAT ↗RegulatoryNeutral

A proposed executive order that would have given the White House significant authority over National Institutes of Health grant awards is now considered dead.

The plan called for a commission of political appointees, including the Office of Management and Budget director, to have veto power over grant decisions, a move critics said would politicize funding.

Senator Susan Collins, chair of the appropriations committee, sent a letter to OMB Director Russell Vought and NIH Director Jay Bhattacharya urging the administration not to proceed, arguing that grants should be awarded on scientific merit.

The bipartisan pushback, reported by Semafor, appears to have halted the executive order, leaving NIH grant processes unchanged for now.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “White House plan to increase control of NIH grants appears ‘dead’”

read at STAT ↗
793 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health2

related stories

  • Jun 5STAT+: What stripping civil service protections for thousands of federal workers will mean for HHSSTAT
  • Jun 5Tiny HHS office tasked with protecting research participants’ safety is running on fumesSTAT
  • Jun 4STAT+: RFK Jr.’s second year: Vacancies, not vaccinesSTAT
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT
  • Jun 4STAT+: Trump administration to strip job protections of top NIH officials, grants staffSTAT